ATE361091T1 - Behandlung von unfruchtbarkeit - Google Patents

Behandlung von unfruchtbarkeit

Info

Publication number
ATE361091T1
ATE361091T1 AT00906177T AT00906177T ATE361091T1 AT E361091 T1 ATE361091 T1 AT E361091T1 AT 00906177 T AT00906177 T AT 00906177T AT 00906177 T AT00906177 T AT 00906177T AT E361091 T1 ATE361091 T1 AT E361091T1
Authority
AT
Austria
Prior art keywords
woman
infertility
treatment
hormone
vitro
Prior art date
Application number
AT00906177T
Other languages
English (en)
Inventor
Christian Grondahl
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE361091T1 publication Critical patent/ATE361091T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Inorganic Insulating Materials (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Ceramic Capacitors (AREA)
AT00906177T 1999-02-24 2000-02-23 Behandlung von unfruchtbarkeit ATE361091T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900256 1999-02-24
US13066299P 1999-04-23 1999-04-23
DKPA199901307 1999-09-16

Publications (1)

Publication Number Publication Date
ATE361091T1 true ATE361091T1 (de) 2007-05-15

Family

ID=27220547

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906177T ATE361091T1 (de) 1999-02-24 2000-02-23 Behandlung von unfruchtbarkeit

Country Status (12)

Country Link
US (1) US6281013B1 (de)
EP (1) EP1156821B1 (de)
JP (1) JP2002537348A (de)
KR (1) KR20010093276A (de)
AT (1) ATE361091T1 (de)
AU (1) AU2794000A (de)
CA (1) CA2363074A1 (de)
CZ (1) CZ20012968A3 (de)
DE (1) DE60034662T2 (de)
ES (1) ES2286008T3 (de)
HU (1) HUP0200079A3 (de)
WO (1) WO2000050065A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2794100A (en) * 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
AU2001263924A1 (en) * 2000-05-18 2001-11-26 Novo-Nordisk A/S Fertilization of aged oocytes
US6623422B2 (en) * 2001-01-12 2003-09-23 Napoli, Llc Method and apparatus for assisted embryo implantation
EP1351612B1 (de) * 2001-01-12 2007-10-03 Napoli, LLC Intrauterin-Mikrokatheter
US8465412B2 (en) * 2001-01-12 2013-06-18 Michael Levy Uterine devices and method of use
US6758806B2 (en) 2001-01-12 2004-07-06 Napoli, Llc Endoscopic devices and method of use
US20060183973A1 (en) * 2001-01-12 2006-08-17 Kamrava Michael M Endoscopic devices and method of use
EP1245572A1 (de) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol-Verbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Medikamenten und ein Vefahren zu ihrer Herstellung
US7033314B2 (en) * 2002-01-11 2006-04-25 Fidelitycorp Limited Endoscopic devices and method of use
US20030135876A1 (en) * 2002-01-16 2003-07-17 Larry Mobraaten Maintenance of genetic lines using cryopreserved sperm
WO2003076600A2 (en) 2002-03-08 2003-09-18 Mcgill University In vitro maturation of immature human oocytes
RU2307687C2 (ru) * 2003-03-05 2007-10-10 Санкт-Петербургская медицинская академия последипломного образования Применение фотогемотерапии в программе подготовки пациентов к экстракорпоральному оплодотворению
EP1550447A1 (de) * 2004-01-02 2005-07-06 Schering Aktiengesellschaft Menstruationszykluskontrolle und Verbesserung der weiblichen Empfängnisrate
WO2005113752A2 (en) 2004-05-17 2005-12-01 The General Hospital Corporation Methods and compositions for producing germ cells from peripheral blood derived germline stem cells
KR101747983B1 (ko) 2009-08-22 2017-06-15 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 배아, 난모세포, 그리고 줄기 세포의 이미징과 평가
CN103517676A (zh) 2010-09-27 2014-01-15 奥克索金股份有限公司 用于胚胎、卵母细胞和干细胞的自动化成像和评价的装置、方法和系统
CN103460038A (zh) 2011-02-23 2013-12-18 里兰斯坦福初级大学理事会 检测人类胚胎中的非整倍性的方法
NZ706806A (en) 2011-04-14 2016-12-23 Gen Hospital Corp Compositions and methods for autologous germline mitochondrial energy transfer
EP2726601B1 (de) 2011-06-29 2018-12-26 The General Hospital Corporation Zusammensetzungen und verfahren zur verbesserung des bioenergetischen status bei weiblichen keimzellen
US20150272622A1 (en) * 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
EP2855694B1 (de) 2012-05-31 2018-12-26 Progyny, Inc. In-vitro-verfahren zur vorhersage von blastozysten
ES2755878T3 (es) 2013-02-01 2020-04-24 Ares Trading Sa Fenotipos anormales de singamia observados con obtención de imágenes a intervalos de tiempo preestablecidos para identificación precoz de embriones con potencial de desarrollo inferior
EP3120297B1 (de) 2014-03-20 2020-12-02 Ares Trading S.A. Quantitative messung von menschlichen blastozysten und der entwicklungskinetik der morulamorphologie
EP4200404A4 (de) 2020-10-22 2025-01-01 The Regents of University of California Vorrichtungen und verfahren zur beurteilung der lebensfähigkeit von embryos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
EP0813595A1 (de) * 1995-03-06 1997-12-29 Novo Nordisk A/S Anregung der meiose
ATE254628T1 (de) * 1995-06-23 2003-12-15 Novo Nordisk As Meiose regulierende verbindungen.
AU6122696A (en) * 1995-06-23 1997-01-22 Novo Nordisk A/S Meiosis regulating compounds
EP0946584B1 (de) * 1996-12-20 2003-04-23 Novo Nordisk A/S Verbindungen zur Regulierung der Meiose
IL132799A0 (en) * 1997-06-04 2001-03-19 Akzo Nobel Nv 17Beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
US5866599A (en) * 1997-06-06 1999-02-02 Basf Aktiengesellschaft Fungicidal mixtures

Also Published As

Publication number Publication date
DE60034662T2 (de) 2008-01-03
WO2000050065A1 (en) 2000-08-31
EP1156821A1 (de) 2001-11-28
EP1156821B1 (de) 2007-05-02
US6281013B1 (en) 2001-08-28
KR20010093276A (ko) 2001-10-27
CA2363074A1 (en) 2000-08-31
HUP0200079A3 (en) 2002-06-28
JP2002537348A (ja) 2002-11-05
HUP0200079A2 (hu) 2002-05-29
DE60034662D1 (de) 2007-06-14
CZ20012968A3 (cs) 2002-01-16
ES2286008T3 (es) 2007-12-01
AU2794000A (en) 2000-09-14

Similar Documents

Publication Publication Date Title
DE60034662D1 (de) Behandlung von unfruchtbarkeit
DE69022722D1 (de) Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
DE69925024D1 (de) Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten
DE69620241D1 (de) Gonadotropin releasing hormon- antagonisten
ES2187642T3 (es) Compuestos de carbamato triciclicos utiles para la inhibicion de la funcion de la proteina g y para el tratamiento de enfermedades proliferativas.
DE69735514D1 (de) Vorrichtung zur Behandlung von Halbleiterscheiben
DE60138553D1 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von hypogonadismus
ES2009948A6 (es) Procedimiento de preparacion de una proteina procedente de una hormona estimulante folicular urinaria, mediante proceso de inmunopurificacion de un concentrado urinario post-menopausico.
DK0736039T3 (da) Forbindelser med væksthormon-frigivende egenskaber
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
ATE424209T1 (de) Verwendung von gnrh-agonisten zur unterstützung der lutealphase während einer unfruchtbarkeitsbehandlung
EA200300944A1 (ru) Ацилированные пиперидиновые производные в качестве агонистов рецептора-4 меланокортина
DE69533991D1 (de) Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
NO982731L (no) Antagonister av gonadotropinfrigivende hormon
BR0107943A (pt) Sìtios de entrada de ribossoma internos sintéticos e métodos de identificar os mesmos
DE69700249D1 (de) Verfahren zur behandlung von tieren, insbesondere zur deren fütterung
Demanno et al. Steroid-induced final maturation in brook trout (Salvelinus fontinalis) oocytes in vitro: the effects of forskolin and phosphodiesterase inhibitors
DE60018707D1 (de) Anti-androgene und verfahren zur behandlung von krankheiten
ATE317266T1 (de) In vitro methode zur synchronisation von oozytenreifung
ATE344661T1 (de) Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen
ATE252910T1 (de) Methode zur behandlung von fruchtbarkeitsstörungen
WO2003076600A3 (en) In vitro maturation of immature human oocytes
DE69927154D1 (de) Vorrichtung und verfahren zur behandlung von erektionsstörungen
EP0909172A4 (de) Verfahren und zusammensetzungen zur behandlung von harninkontinenz unter verwendung von enantiomer-angereichertem (r,s)-glycopyrrolat
DE69902999D1 (de) Glucocorticoide zur behandlung von glomerulonephitis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties